Evidence map›Paper›PMID 18364471›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2008

Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.

Chaoqin Xie, Jeffrey R Sachs, Donna H Wang

Open access · greenAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. TRPV4 channels contribute to renal myogenic autoregulation in neonatal pigs.American journal of physiology. Renal physiology · 2017
    Article
  9. Role of renal sensory nerves in physiological and pathophysiological conditions.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Review
  10. Review
  11. Article
  12. P2Y2 receptors mediate ATP-induced resensitization of TRPV1 expressed by kidney projecting sensory neurons.American journal of physiology. Regulatory, integrative and comparative physiology · 2010
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chaoqin XieDepartment of Medicine, Michigan State University, East Lansing, MI 48824, USA.
Jeffrey R Sachs
Donna H Wang
Michigan State University · US

Funding

Vanilloid Sensitive Sensory Nerves and Salt SensitivityR01HL073287 · NHLBI · MICHIGAN STATE UNIVERSITY · PI WANG, DONNA H · 2004 to 2011
$2.7M
Molecular Sensing of Sodium Homeostasis: Anandamide RoleR01DK067620 · NIDDK · MICHIGAN STATE UNIVERSITY · PI WANG, DONNA H · 2005 to 2009
$1.4M
RENAL ANGIOTENSIN II RECEPTOR AND SODIUM INTAKER01HL057853 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WANG, DONNA H · 1998 to 2007
$1.1M
NHLBI NIH HHS R01 HL057853NHLBI NIH HHS R01 HL073287NIDDK NIH HHS R01 DK067620
6 · The paper itself

Abstract

Our previous studies have shown that the activation of the transient receptor potential vanilloid type 1 (TRPV1) expressed in the renal pelvis leads to an increase in ipsilateral afferent renal nerve activity (ARNA) and contralateral renal excretory function, but the molecular mechanisms of TRPV1 action are largely unknown. This study tests the hypothesis that activation of receptors of neurokinin 1 (NK1) or calcitonin gene-related peptide (CGRP) by endogenously released substance P (SP) or CGRP following TRPV1 activation, respectively, governs TRPV1-induced increases in ARNA and renal excretory function. Capsaicin (CAP; 0.04, 0.4, and 4 nM), a selective TRPV1 agonist, administered into the renal pelvis dose-dependently increased ARNA. CAP (4 nM)-induced increases in ipsilateral ARNA or contralateral urine flow rate (Uflow) and urinary sodium excretion (UNa) were abolished by capsazepine (CAPZ), a selective TRPV1 antagonist, or 2-[1-imino-2-(2-methoxyphenyl)ethyl]-7,7-diphenyl-4-perhydroisoindolone (3aR,7aR) (RP67580) or cis-2-(diphenylmethyl)-N-[(2-iodophenyl)-methyl]-1 azabicyclo[2.2.2]octan-3-amine (L703,606), selective NK1 antagonists, but not by CGRP8-37, a selective CGRP receptor antagonist. Both SP (7.4 nM) and CGRP (0.13 muM) increased ARNA, Uflow, or UNa, and increases in these parameters induced by CGRP but not SP were abolished by CAPZ. CAP at 4 nM perfused into the renal pelvis caused the release of SP and CGRP, which was blocked by CAPZ but not by RP67580, L703,606, or CGRP8-37. Immunofluorescence results showed that NK1 receptors were expressed in sensory neurons in dorsal root ganglion and sensory nerve fibers innervating the renal pelvis. Taken together, our data indicate that NK1 activation induced by SP release upon TRPV1 activation governs TRPV1 function and that a TRPV1-dependent mechanism is operant in CGRP action.

Indexed as

AnimalsBlood PressureCalcitonin Gene-Related PeptideCalcitonin Gene-Related Peptide Receptor AntagonistsCapsaicinGanglia, SpinalIsoindolesKidney PelvisMaleNeurokinin-1 Receptor AntagonistsNeurons, AfferentPeptide FragmentsQuinuclidinesRatsRats, WistarReceptors, Calcitonin Gene-Related Peptide7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-oneCalcitonin Gene-Related Peptidecalcitonin gene-related peptide (8-37)Calcitonin Gene-Related Peptide Receptor AntagonistsCapsaicincapsazepineIsoindolesL 703606Neurokinin-1 Receptor AntagonistsPeptide FragmentsQuinuclidinesReceptors, Calcitonin Gene-Related PeptideReceptors, Neurokinin-1Substance PTrpv1 protein, ratTRPV Cation Channels

Identifiers

PMID18364471
PMCPMC2689370
OpenAlexW2115047355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.